Halozyme Therapeutics Inc (NASDAQ:HALO)

19.47
Delayed Data
As of 4:15pm ET
 +0.30 / +1.56%
Today’s Change
11.41
Today|||52-Week Range
21.48
-3.90%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Torley Helen I
President & Chief Executive Officer
Sale2/03/201824,111$18.37$442.9K+9.63%
Torley Helen I
President & Chief Executive Officer
Sale2/22/201819,511$19.28$376.2K+0.99%
Torley Helen I
President & Chief Executive Officer
Sale2/06/201815,493$18.25$282.7K+6.68%
Torley Helen I
President & Chief Executive Officer
Sale1/06/201811,649$19.46$226.7K+4.01%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/03/20188,265$18.37$151.8K+9.63%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/03/20185,605$18.37$103.0K+9.63%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale2/22/20183,939$19.28$75.9K+0.99%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale2/22/20183,939$19.28$75.9K+0.99%
Stelzer Laurie D
Chief Financial Officer & Senior Vice President
Sale6/15/20183,254$19.02$61.9K+2.37%
Leonhardt Harry J
Chief Compliance Officer, SVP & General Counsel
Sale4/13/20182,377$19.37$46.0K+0.52%
Page of 3